Staphylococcus aureus exotoxins are present In Vivo in tampons

Clinical and Vaccine Immunology

Volumn 17, Issue 5, 2010, Pages 722-727

  Schlievert, Patrick M ^a   Nemeth, Kimberly A ^c   Davis, Catherine C ^c   Peterson, Marnie L ^b   Jones, Bruce E ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BACTERIUM ANTIBODY; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TOXIC SHOCK SYNDROME TOXIN 1;

ANTIBODY TITER; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; FEMALE; HUMAN; MENSTRUATION; NONHUMAN; PH; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TAMPON; TOXIC SHOCK SYNDROME;

BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CYTOKINES; ENTEROTOXINS; FEMALE; HEMOLYSIN PROTEINS; HUMAN EXPERIMENTATION; HUMANS; HYDROGEN-ION CONCENTRATION; MENSTRUAL HYGIENE PRODUCTS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 77952002498     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00483-09     Document Type: Article

References (36)

1. Bergdoll, M. S., B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet i:1017-1021.
2. Bergdoll, M. S., and P. M. Schlievert. 1984. Toxic-shock syndrome toxin. Lancet ii:691.
3. Blake, M. S., K. H. Johnston, G. J. Russell-Jones, and E. C. Gotschlich. 1984. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal. Biochem. 136:175-179.
4. Blomster-Hautamaa, D. A., and P. M. Schlievert. 1988. Preparation of toxic shock syndrome toxin-1. Methods Enzymol. 165:37-43.
5. Davis, C. C., M. J. Kremer, P. M. Schlievert, and C. A. Squier. 2003. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189:1785-1791.
6. Davis, J. P., P. J. Chesney, P. J. Wand, and M. LaVenture. 1980. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303:1429-1435.
7. Fichorova, R. N., and D. J. Anderson. 1999. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol. Reprod. 60:508-514.
8. Gaventa, S., A. L. Reingold, A. W. Hightower, C. V. Broome, B. Schwartz, C. Hoppe, J. Harwell, L. K. Lefkowitz, S. Makintubee, D. R. Cundiff, et al. 1989. Active surveillance for toxic shock syndrome in the United States, 1986. Rev. Infect. Dis. 11:S28-S34.
9. Giantonio, B. J., R. K. Alpaugh, J. Schultz, C. McAleer, D. W. Newton, B. Shannon, Y. Guedez, M. Kotb, L. Vitek, R. Persson, P. O. Gunnarsson, T. Kalland, M. Dohlsten, B. Persson, and L. M. Weiner. 1997. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody- staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer. J. Clin. Oncol. 15:1994-2007.
10. Hill, D. R., M. E. Brunner, D. C. Schmitz, C. C. Davis, J. A. Flood, P. M. Schlievert, S. Z. Wang-Weigand, and T. W. Osborn. 2005. In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J. Appl. Physiol. 99:1582-1591.
11. Kansal, R., C. Davis, M. Hansmann, J. Seymour, J. Parsonnet, P. Modern, S. Gilbert, and M. Kotb. 2007. Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome. J. Clin. Immunol. 27:327-338.
12. Kass, E. H., M. I. Kendrick, Y. C. Tsai, and J. Parsonnet. 1987. Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. J. Infect. Dis. 155:812-815.
13. Kotb, M., A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M. T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, B. Schwartz, and D. E. Low. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:1398-1404.
14. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
16. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
17. Onderdonk, A. B., G. R. Zamarchi, M. L. Rodriguez, M. L. Hirsch, A. Munoz, and E. H. Kass. 1987. Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl. Environ. Microbiol. 53:2774-2778.
18. Parsonnet, J., M. A. Hansmann, M. L. Delaney, P. A. Modern, A. M. Dubois, W. Wieland-Alter, K. W. Wissemann, J. E. Wild, M. B. Jones, J. L. Seymour, and A. B. Onderdonk. 2005. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this super-antigen in menstruating women. J. Clin. Microbiol. 43:4628-4634.
19. Peterson, M., K. Ault, M. J. Kremer, A. J. Klingelhutz, C. C. Davis, C. A. Squier, and P. M. Schlievert. 2005. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect. Immun. 73:2164-2174.
20. Reingold, A. L., C. V. Broome, S. Gaventa, and A. W. Hightower. 1989. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Rev. Infect. Dis. 11:S35-S41.
21. Reingold, A. L., N. T. Hargrett, B. B. Dan, K. N. Shands, B. Y. Strickland, and C. V. Broome. 1982. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann. Intern. Med. 96:871-874.
22. Rosten, P. M., K. H. Bartlett, and A. W. Chow. 1987. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay. J. Clin. Microbiol. 25:327-332.
23. Schlievert, P. M. 1988. Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol. 165:339-344.
24. Schlievert, P. M. 1986. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet i:1149-1150.
25. Schlievert, P. M., and D. A. Blomster. 1983. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147:236-242.
26. Schlievert, P. M., L. C. Case, K. A. Nemeth, C. C. Davis, Y. Sun, W. Qin, F. Wang, A. J. Brosnahan, J. A. Mleziva, M. L. Peterson, and B. E. Jones. 2007. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry 46:14349-14358.
27. Schlievert, P. M., L. C. Case, K. L. Strandberg, T. J. Tripp, Y. C. Lin, and M. L. Peterson. 2007. Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. J. Clin. Microbiol. 45:2704-2707.
28. Schlievert, P. M., M. T. Osterholm, J. A. Kelly, and R. D. Nishimura. 1982. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann. Intern. Med. 96:937-940.
29. Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, and R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J. Infect. Dis. 143:509-516.
30. Schlievert, P. M., T. J. Tripp, and M. L. Peterson. 2004. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 42:2875-2876.
31. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436-1442.
32. Todd, J. K., F. A. Kapral, M. Fishaut, and T. R. Welch. 1978. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet ii:1116-1118.
33. Todd, J. K., B. H. Todd, A. Franco-Buff, C. M. Smith, and D. W. Lawellin. 1987. Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J. Infect. Dis. 155:673-681.
34. Veeh, R. H., M. E. Shirtliff, J. R. Petik, J. A. Flood, C. C. Davis, J. L. Seymour, M. A. Hansmann, K. M. Kerr, M. E. Pasmore, and J. W. Costerton. 2003. Detection of Staphylococcus aureus biofilm on tampons and menses components. J. Infect. Dis. 188:519-530.
35. Vergeront, J. M., S. J. Stolz, B. A. Crass, D. B. Nelson, J. P. Davis, and M. S. Bergdoll. 1983. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J. Infect. Dis. 148:692-698.
36. Yarwood, J. M., and P. M. Schlievert. 2000. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J. Clin. Microbiol. 38:1797-1803.